The latest development in the Pradaxa multidistrict litigation (MDL) in the U.S. District Court for the Southern District of Illinois involves a recently filed court document from mid-September. Both parties…
Read More
A plaintiff in a Pradaxa bleeding risk lawsuit was recently granted approval to move forward with his suit. In the Pradaxa lawsuit, the plaintiff claims that the pharmaceutical company behind…
Read More
Published August 27, 2012 on PR Web St. Louis, Missouri (PRWEB) August 27, 2012 For individuals who have incurred injuries from Pradaxa use, attorneys at Carey Danis & Lowe are…
Read More
The NuvaRing mass tort in New Jersey recently convened on June 19, 2013 for a case management conference amid news that the first NuvaRing lawsuit consolidated into the mass tort…
Read More
According to a recent Madison-St. Clair Record article, NuvaRing lawsuits have recently been filed in the U.S. District Court for the Southern District of Illinois charging five defendants, among them…
Read More
New Pradaxa Analysis Underscores Pradaxa Deaths and Urgency of Further Pradaxa Safety Investigations
In January, the Institute for Safe Medication Practices (ISMP) released a report with their safety analysis of three anticoagulant medications, including Pradaxa, warfarin, and Xarelto. The ISMP found that approximately…
Read More
Levaquin, a drug manufactured by a Johnson & Johnson subsidiary – OrthoMcNeil Pharmaceutical, Inc. – is the topic of several lawsuits around the country that have since been consolidated into…
Read More
Court convened on January 8, 2013 for a Status Conference for Levaquin lawsuits that have been consolidated into In Re: Levaquin Products Liability Litigation, the Multi-District Litigation (MDL) that is…
Read More
In current Levaquin lawsuit news, it has become apparent that fluoroquinolones, like Levaquin (levofloxacin), is the cause of more than just tendon damage, as previously understood. In a recent New…
Read More
In 2003, Takeda Pharmaceuticals Inc. expressed concerns about whether Actos users could develop cancer. These reservations on the part of the Japanese pharmaceutical company came to light in court documents…
Read More